---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-039218"
form_type: "8-K"
ticker: "BCTX"
cik: "0001610820"
company_name: "BriaCell Therapeutics Corp."
filed_at: "2024-10-02T23:59:59+00:00"
generated_at: "2026-05-30T22:34:18.431849+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BriaCell closes $5M offering of 5.1M shares and warrants at $0.975/unit

## Summary
- 5,128,500 common shares and warrants to purchase 5,128,500 common shares sold at $0.975 per unit.
- Gross proceeds ~$5M; warrants exercisable at $0.85/share for five years from issuance.
- Proceeds for working capital, general corporate purposes, and business advancement.
- ThinkEquity acted as sole placement agent; placement agent warrants issued.
- Offering closed October 2, 2024, under effective shelf registration statement.

## SEC filing metadata
- accession: 0001493152-24-039218
- form_type: 8-K
- ticker: BCTX
- cik: 0001610820
- company_name: BriaCell Therapeutics Corp.
- filed_at: 2024-10-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610820/000149315224039218/0001493152-24-039218-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610820/000149315224039218/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-039218
- JSON: https://secwatch.observer/filing/0001493152-24-039218.json
- Plain text: https://secwatch.observer/filing/0001493152-24-039218.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.